Kathleen Duerksen, MD
Ophthalmic Plastic and Reconstructive Surgery · Tucson, AZNPI 1417966607
Payments from drug & device makers
Across 74 payments — averaging $68.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- AbbVie$676
- Ventana Medical Systems, Inc.$552
- Galderma Laboratories, L.p.$536
- Merz North America, Inc.$375
- Regeneron Healthcare Solutions, Inc.$239
- plus $2K from 16 others
What the payments were for
- Speaking & faculty fees$95019%
- Food & beverage$4,15081%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 33 | $1,087 |
| AbbVie(2 entities) | 7 | $676 |
| Ventana Medical Systems, Inc. | 2 | $552 |
| Galderma Laboratories, L.p. | 7 | $536 |
| Merz North America, Inc. | 5 | $375 |
| Regeneron Healthcare Solutions, Inc. | 3 | $239 |
| Integra Lifesciences Corporation | 2 | $187 |
| Mallinckrodt Hospital Products Inc. | 1 | $146 |
| Smith+Nephew | 1 | $136 |
| Rxsight Inc | 1 | $134 |
| Biotissue Holdings Inc. | 1 | $129 |
| Alcon | 1 | $125 |
| Glaukos Corporation | 1 | $124 |
| Bausch & Lomb Americas Inc. | 1 | $123 |
| Novartis | 1 | $117 |
| Alafair Biosciences, Inc. | 1 | $91 |
| Silk Road Medical, Inc. | 1 | $87 |
| Johnson & Johnson | 1 | $85 |
| Genentech USA, Inc. | 1 | $57 |
| Abbott | 1 | $48 |
| Apyx Medical Corporation | 1 | $35 |
| Ocular Therapeutix, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VENTANA RESEARCH & DEVELOPMENT$500
- TEPEZZA$459
- INTEGRA$236
- ACTHAR$146
- GRAFIX PL$136
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$134
- NATRELLE SALINE-FILLED BREAST IMPLANTS$133
- Prokera$129
- AmnioGraft$129
- Rocklatan$125
- Rhopressa$125
- iStent$124
- LOTEMAX SM$123
- LIBTAYO$122
- OMNIGRAFT$118
- SURGIMEND$118
- INTEGRA DERMAL REGENERATION TEMPLATE$118
- DURYSTA$115
How this compares
Too few ophthalmic plastic and reconstructive surgery providers in Arizonato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 183 | $1,711 |
| ErythromycinErythromycin Base | 125 | $1,279 |
| Cephalexin | 16 | $99 |
Paid to pharmacies, not to this prescriber.
Other ophthalmic plastic and reconstructive surgery in Tucson
- Mikel LoTucson$3K
- Lorne SchlechtLake Havasu City$28K
- Denise GarciaMesa$2K
- Grant MoorePhoenix$1K
- Lisa MansuetoTempe$1K
- Benjamin CampbellMesa$789
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.